Skip to content
10-K

Annual Report

MEDICINOVA, INC. MNOV

0000950170-25-023301

← back to feed
Filed
Feb 19, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 17, 2025 49.05M sh
Shares Diluted FY 2024 · Dec 31, 2023 49.05M sh
Capex FY 2024 · Dec 31, 2023 $21.3K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$7.43M
Cash And Equivalents FY 2024 · Dec 31, 2023 $51M
Current Liabilities FY 2024 · Dec 31, 2023 $3.28M
Total Liabilities FY 2024 · Dec 31, 2023 $3.89M
Current Assets FY 2024 · Dec 31, 2023 $51.17M
Total Assets FY 2024 · Dec 31, 2023 $66.27M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.17
Eps Basic FY 2024 · Dec 31, 2023 −$0.17
Sga Expense FY 2024 · Dec 31, 2023 $5.24M
Rd Expense FY 2024 · Dec 31, 2023 $5.3M
Net Income FY 2024 · Dec 31, 2023 −$8.57M
Operating Income FY 2024 · Dec 31, 2023 −$9.9M
Revenue FY 2024 · Dec 31, 2023 $1M